L474 Pill - green oval
Generic Name: umbralisib
Pill with imprint L474 is Green, Oval and has been identified as Ukoniq 200 mg. It is supplied by TG Therapeutics, Inc.
Ukoniq is used in the treatment of Follicular Lymphoma; Marginal Zone Lymphoma and belongs to the drug class multikinase inhibitors. Ukoniq 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L474
Ukoniq
- Generic Name
- umbralisib
- Imprint
- L474
- Strength
- 200 mg
- Color
- Green
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TG Therapeutics, Inc.
- National Drug Code (NDC)
- 73150-0200
More about Ukoniq (umbralisib)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
